Soboleski D A, Li-Kwong-Ken M C, Wynn H, Triggle C R, Wolowyk M W, Knaus E E
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.
Drug Des Deliv. 1988 Feb;2(3):177-89.
Calcium channel antagonist activities of the 1,2-dihydropyridines (9) were determined using the muscarinic-receptor mediated Ca2+ dependent contraction of guinea pig ileal longitudinal smooth muscle. The relative potency order for 4-substituted analogs 9 was phenyl greater than 3-trifluoromethyl(nitro)phenyl greater than 4- and 2-trifluoromethyl(nitro)phenyl. Increasing the size of the alkyl ester substituents (9h) enhanced activity. The test results indicate that the 1,2-dihydropyridyl ring system (9) is partially bioisosteric with the 1,4-dihydropyridyl ring system (10). Competitive [3H]-nitrendipine binding studies indicated that the affinities of the 1,2-dihydropyridine analogues were much lower than expected from their ID50 activities, suggesting that these analogues inhibit calcium channels by a different receptor mechanism. In the synthetic work, Hantzsch condensation of aldehydes (3) with alkyl acetoacetates (4) afforded 3,5-dialkyl 2,6-dimethyl-4-(substituted-phenyl)-1,4-dihydropyridine-3,5-dicarboxylat es (5). Oxidation of 5 gave the aromatic pyridines (6) which were elaborated to the l-methylpyridinium methyl sulphates (7) and then to the perchlorates (8). Sodium borohydride reduction of 8 in aqueous ethanol gave 3,5-dialkyl 1,2,6-trimethyl-4-(substituted-phenyl)-1,2-dihydropyridine-3, 5-dicarboxylates (9).
使用毒蕈碱受体介导的豚鼠回肠纵行平滑肌钙依赖性收缩来测定1,2 -二氢吡啶(9)的钙通道拮抗剂活性。4 -取代类似物9的相对效价顺序为:苯基大于3 -三氟甲基(硝基)苯基大于4 -和2 -三氟甲基(硝基)苯基。增加烷基酯取代基(9h)的大小可增强活性。测试结果表明,1,2 -二氢吡啶环系统(9)与1,4 -二氢吡啶环系统(10)部分生物电子等排。竞争性[3H] - 尼群地平结合研究表明,1,2 -二氢吡啶类似物的亲和力远低于根据其半数抑制浓度(ID50)活性预期的值,这表明这些类似物通过不同的受体机制抑制钙通道。在合成工作中,醛(3)与乙酰乙酸烷基酯(4)的汉茨希缩合反应得到3,5 -二烷基2,6 -二甲基 - 4 -(取代苯基)-1,4 -二氢吡啶 - 3,5 -二羧酸酯(5)。5的氧化反应得到芳香吡啶(6),将其进一步转化为1 -甲基吡啶甲基硫酸盐(7),然后再转化为高氯酸盐(8)。在乙醇水溶液中用硼氢化钠还原8得到3,5 -二烷基1,2,6 -三甲基 - 4 -(取代苯基)-1,2 -二氢吡啶 - 3,5 -二羧酸酯(9)。